Latest financial market updates and expert analysis
Healthcare Shares of the telehealth provider Hims & Hers Health have experienced a dramatic rally following a major strategic reversal and the resolution of a legal dispute. The company is shifting...
The narrative surrounding hydrogen technology firm Plug Power has long been dominated by significant losses and unmet targets. However, recent...
Biotechnology firm Scholar Rock is poised to make a significant strategic shift from a development-stage company to a commercial entity....
Ultragenyx Pharmaceutical has reported significant progress in its clinical development for a rare genetic disorder. New data from a Phase...
The lidar technology firm Microvision is navigating a critical strategic shift. Having focused on research for years, the company is...
The biopharmaceutical firm Axsome Therapeutics is executing an aggressive growth strategy centered on commercial expansion and a rich development pipeline....
While The Trade Desk closed its last fiscal year with a solid increase in profit, the advertising technology specialist is...
Wall Street’s attention has turned to biotech firm Ocugen as it advances its gene therapy programs for inherited retinal diseases....
Pharmaceutical giant Eli Lilly is executing a simultaneous two-front strategy to solidify its commanding position in the multi-billion dollar weight-loss...
Energy giant Shell finds itself operating on two critical geopolitical fronts simultaneously. The company is currently managing supply disruptions from...
Heidelberg Materials has permanently closed its cement plant in Paderborn, Germany, marking a decisive move in response to persistent weakness...
